InvestSMART

Acusensus Limited (ASX: ACE) - Announcements

- Current share price for ACE : $1.260

ASX company news and announcements for Acusensus Limited (ACE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acusensus Limited (ACE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acusensus Limited (ACE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acusensus Limited (ACE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$213 Acusensus signs Service Delivery SOW for NZ speed program 1 Jul 2025 8:26AM $0.950 $1.260 risen by 32.63%
$213 Legal proceedings by Redflex Traffic Systems Pty Ltd 18 Jun 2025 4:46PM $1.000 $1.260 risen by 26%
$213 Application for quotation of securities - ACE 3 Jun 2025 9:14AM $0.940 $1.260 risen by 34.04%
$213 Wilsons Rapid Insights Conference Presentation 22 May 2025 8:20AM $1.055 $1.260 risen by 19.43%
$213 Q3 FY25 Business Update 1 May 2025 8:35AM $1.050 $1.260 risen by 20%
$213 Change of Addresses 14 Apr 2025 8:22AM $1.010 $1.260 risen by 24.75%
$213 Notification of cessation of securities - ACE 2 Apr 2025 6:02PM $1.060 $1.260 risen by 18.87%
$213 Notification regarding unquoted securities - ACE 2 Apr 2025 6:00PM $1.060 $1.260 risen by 18.87%
$213 ASX SMIDcaps Conference - Acusensus Presentation 26 Mar 2025 8:22AM $1.085 $1.260 risen by 16.13%
$213 Application for quotation of securities - ACE 5 Mar 2025 9:49AM $1.145 $1.260 risen by 10.04%
$213 Application for quotation of securities - ACE 5 Mar 2025 9:24AM $1.145 $1.260 risen by 10.04%
$213 Acusensus awarded new NSW mobile and seatbelt contract 3 Mar 2025 8:18AM $1.150 $1.260 risen by 9.57%
$213 Acusensus 1H FY25 Investor Presentation 27 Feb 2025 8:09AM $1.240 $1.260 risen by 1.61%
$213 Acusensus 1H FY25 Results Release 27 Feb 2025 8:09AM $1.240 $1.260 risen by 1.61%
$213 Acusensus Appendix 4D and Half-Year Financial Report 27 Feb 2025 8:08AM $1.240 $1.260 risen by 1.61%
$213 Acusensus 1H FY25 Results Webinar 31 Jan 2025 8:10AM $1.180 $1.260 risen by 6.78%
$213 Q2 FY25 Quarterly Activities Report and Appendix 4C 30 Jan 2025 8:15AM $1.075 $1.260 risen by 17.21%
$213 Notification of cessation of securities - ACE 3 Jan 2025 5:45PM $1.125 $1.260 risen by 12%
$213 Appendix 3Y - Change of Director's Interest Notices 27 Dec 2024 4:39PM $1.130 $1.260 risen by 11.50%
$213 Ceasing to be a substantial holder 24 Dec 2024 12:01PM $1.140 $1.260 risen by 10.53%
$213 Application for quotation of securities - ACE 24 Dec 2024 8:20AM $1.130 $1.260 risen by 11.50%
$213 Completion of Share Purchase Plan 20 Dec 2024 8:20AM $1.100 $1.260 risen by 14.55%
$213 Change in substantial holding 13 Dec 2024 6:26PM $1.160 $1.260 risen by 8.62%
$213 Change in substantial holding 13 Dec 2024 5:35PM $1.160 $1.260 risen by 8.62%
$213 Change in substantial holding 13 Dec 2024 5:35PM $1.160 $1.260 risen by 8.62%

76 - 100 of 347 results

Page 4 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.